High Expression of CCL20 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma after Curative Resection

被引：0
|
作者：
Xiangjiu Ding
Kexin Wang
Hui Wang
Guangyong Zhang
Yajing Liu
Qingyun Yang
Weijie Chen
Sanyuan Hu
机构：
[1] Qilu Hospital,Department of General Surgery
[2] Shandong University,Institute of Cell Therapy
[3] Shandong University,Department of Surgery and Molecular Oncology, Ninewells Hospital and Medical School
[4] University of Dundee,undefined
来源：
Journal of Gastrointestinal Surgery | 2012年 / 16卷
关键词：
Hepatocellular carcinoma; CCL20; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：828 / 836
页数：8
相关论文
共 50 条
  • [1] High Expression of CCL20 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma after Curative Resection
    Ding, Xiangjiu
    Wang, Kexin
    Wang, Hui
    Zhang, Guangyong
    Liu, Yajing
    Yang, Qingyun
    Chen, Weijie
    Hu, Sanyuan
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2012, 16 (04) : 828 - 836
  • [2] HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection
    Zhao, Yi-Ming
    Zhou, Jia-Min
    Wang, Long-Rong
    He, Hong-Wei
    Wang, Xi-Long
    Tao, Zhong-Hua
    Sun, Hui-Chuan
    Wu, Wei-Zhong
    Fan, Jia
    Tang, Zhao-You
    Wang, Lu
    [J]. CANCER, 2012, 118 (10) : 2708 - 2717
  • [3] High GCLC level in tumor tissues is associated with poor prognosis of hepatocellular carcinoma after curative resection
    Sun, Jialei
    Zhou, Chenhao
    Ma, Qianni
    Chen, Wanyong
    Atyah, Manar
    Yin, Yirui
    Fu, Peiyao
    Liu, Shuang
    Hu, Bo
    Ren, Ning
    Zhou, Haijun
    [J]. JOURNAL OF CANCER, 2019, 10 (15): : 3333 - 3343
  • [4] High RPS11 level in hepatocellular carcinoma associates with poor prognosis after curative resection
    Zhou, Chenhao
    Sun, Jialei
    Zheng, Zhiyuan
    Weng, Jialei
    Atyah, Manar
    Zhou, Qiang
    Chen, Wanyong
    Zhang, Yuan
    Huang, Jiaxing
    Yin, Yirui
    Mao, Huarong
    Zhang, Ziping
    Yi, Yong
    Ren, Ning
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (07)
  • [5] High S100A9+ cell density predicts a poor prognosis in hepatocellular carcinoma patients after curative resection
    Liao, Jing
    Li, Jin-Zhu
    Xu, Jing
    Xu, Yongquan
    Wen, Wei-Ping
    Zheng, Limin
    Li, Lian
    [J]. AGING-US, 2021, 13 (12): : 16367 - 16380
  • [6] High expression of myofibrillogenesis regulator-1 predicts poor prognosis for patients with hepatocellular carcinoma after curative hepatectomy
    Wang, Chunwei
    Xiang, Hua
    Si, Huiyuan
    Guo, Dandan
    Sun, Mei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (11): : 14818 - 14823
  • [7] High cathepsin A protein expression predicts poor prognosis and tumor recurrence of hepatocellular carcinoma patients after curative hepatectomy
    Luo, Laibang
    Wang, Xuyang
    Wang, Huaxiang
    Yang, Chengkai
    Zhang, Youfu
    Li, Xinchang
    Xu, Zhidan
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (08): : 3843 - 3856
  • [8] Cytokeratin 10 and cytokeratin 19: Predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection
    Yang, Xin-Rong
    Xu, Yang
    Shi, Guo-Ming
    Fan, Jia
    Zhou, Jian
    Ji, Yuan
    Sun, Hui-Chuan
    Qiu, Shuang-Jian
    Yu, Bing
    Gao, Qiang
    He, Yi-Zhou
    Qin, Weng-Zhen
    Chen, Rong-Xin
    Yang, Guo-Huan
    Wu, Bing
    Lu, Qing
    Wu, Zhi-Quan
    Tang, Zhao-You
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (12) : 3850 - 3859
  • [9] High expression of AP-4 predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy
    Hu, Ben-Shun
    Zhao, Gang
    Yu, Hai-Feng
    Chen, Ke
    Dong, Jia-Hong
    Tan, Jing-Wang
    [J]. TUMOR BIOLOGY, 2013, 34 (01) : 271 - 276
  • [10] High co-expression of vascular endothelial growth factor receptor-1 and Snail is associated with poor prognosis after curative resection of hepatocellular carcinoma
    Tao Li
    Yuhua Zhu
    Wanhua Ren
    Shifeng Xu
    Zhen Yang
    Aiju Fang
    Chengyong Qin
    [J]. Medical Oncology, 2012, 29 : 2750 - 2761
12345